The first China IPO has yet to hit US markets this year, but an industry insider predicts another busy year as many small and mid-size private sector companies continue to favour a listing in New York via American depositary receipts ADRs over markets closer to home.
He is also positive that the key DR market innovations in Asia last year, including Indian DRs, Hong Kong DRs and the ability to trade ADRs in Singapore, will continue to develop as global issuers try to tap into new pools of investable capital outside the US.
Last year marked a record in terms of the number of Chinese companies that listed in the US through...